Mohammadi-Kebar Y, Zandian H, Khazdooz Z. The impact of anti-tumor necrosis factor alpha drugs on lipid profile of patients with rheumatoid arthritis or seronegative spondyloarthropathy. Int J Basic Clin Pharmacol [Internet]. 2023 Dec. 26 [cited 2025 Oct. 23];13(1):47-50. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/5494